Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
72 studies found for:    Open Studies | "Urinary Bladder, Overactive"
Show Display Options
Rank Status Study
21 Recruiting Gene Expression in the Overactive Bladder in Children
Conditions: Overactive Bladder;   Children
Intervention:
22 Recruiting "The Effects of Caffeine on Overactive Bladder Symptoms and Mental Health in Postmenopausal Women"
Conditions: Overactive Bladder;   Caffeine;   Menopause
Interventions: Dietary Supplement: 400 mg of caffeine/day (Two 200mg pills/day);   Dietary Supplement: 200 mg of caffeine/day (One 200mg pill and one placebo pill);   Dietary Supplement: Two placebo pills/day
23 Recruiting Severity of Overactive Bladder Symptoms in Patients After Synergo Treatment
Conditions: Overactive Bladder;   Bladder Cancer;   Synergo
Intervention: Other: Questionnaires, anticholinergic treatment, urodynamic study
24 Not yet recruiting Efficacy And Safety Of Combination Therapy For Treatment Of Overactive Bladder In Male Patients With Benign Prostatic Hyperplasia.
Conditions: Overactive Bladder;   Benign Prostatic Hyperplasia
Interventions: Drug: Mirabegron;   Drug: Tamsulosin
25 Recruiting Comparisons of 3-month Versus 6-month Solifenacin Treatment for Female OAB Patients
Condition: Overactive Bladder Syndrome
Interventions: Drug: Solifenacin for 12 weeks;   Drug: Solifenacin for 24 weeks
26 Recruiting A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH)
Condition: Overactive Bladder
Interventions: Drug: Mirabegron;   Drug: Placebo
27 Recruiting Bryophyllum Pinnatum Versus Solifenacin Versus Placebo for Overactive Bladder
Conditions: Overactive Bladder;   Urge Urinary Incontinence
Intervention: Drug: Bryophyllum
28 Recruiting OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients
Conditions: Urinary Incontinence;   Urinary Bladder, Overactive
Intervention: Biological: OnabotulinumtoxinA
29 Recruiting Time of Effect Onset in Treating Overactive Bladder or Non Obstructive Urinary Retention by Sacral Neuromodulation
Conditions: Overactive Bladder;   Non Obstructive Urinary Retention
Intervention: Behavioral: Filling out voiding diaries.
30 Recruiting Efficacy and Safety Study of GSK1358820 in Japanese Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity
Condition: Urinary Bladder, Overactive
Interventions: Drug: GSK1358820;   Drug: Placebo
31 Recruiting A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)
Conditions: Urinary Bladder Overactive;   Overactive Bladder;   Urinary Bladder Diseases;   Urologic Diseases
Interventions: Drug: mirabegron;   Drug: antimuscarinic medication
32 Recruiting Specified Drug Use-results Survey of Betanis Tablets
Condition: Overactive Bladder
Intervention: Drug: Betanis
33 Recruiting The Effect of an Additional Stress Incontinence Procedure on Overactive Bladder During Pelvic Organ Prolapse Repair
Conditions: Overactive Bladder;   Pelvic Organ Prolapse
Intervention:
34 Recruiting Phase 1 Study in Subjects With OAB Assessing the Safety and Activity of hMaxi-K Gene Transfer
Condition: OAB (Overactive Bladder Syndrome and Detrusor Overactivity)
Interventions: Drug: Placebo (PBS-20% sucrose);   Drug: hMaxi-K
35 Recruiting OnabotulinumtoxinA (onaBoNT-A) Versus Oral Oxybutynin ER
Condition: Overactive Bladder
Interventions: Drug: onaBoNT-A;   Drug: Oxybutynin ER
36 Recruiting PRospective Study to Evaluate EffectivenesS With the NURO™ PErcutaneous Tibial Neuromodulation System in Patients With OAB
Condition: Overactive Bladder
Intervention: Device: NURO System PTNM Therapy
37 Not yet recruiting A Study to Evaluate Safety, Tolerability and Pharmacokinetics of DA-8010 in Healthy Subjects
Condition: Overactive Bladder
Interventions: Drug: DA-8010;   Drug: Placebo
38 Recruiting Instillation of Botox in the Bladder
Condition: Overactive Bladder
Intervention: Drug: onabotulinum toxin A
39 Recruiting Mirabegron and Urinary Urgency Incontinence
Condition: Overactive Bladder
Intervention: Drug: mirabegron
40 Recruiting Cystoscopic Ablation Via RF Energy Clinical Trial (CARET 2)
Condition: Overactive Bladder
Intervention: Device: Amphora OAB Device 3.0 mm

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.